Entia Biosciences, Inc.: 10-Q filed 2016-11-14

Name: Entia Biosciences, Inc.: 10-Q filed 2016-11-14
Creator: Entia Biosciences, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Entia Biosciences, Inc. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 35 published measures, 92 facts as tagged in accession 0001185185-16-005749.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q3 2016
Accession: 0001185185-16-005749 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Entia Biosciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	365,827	USD
At 2015-12-31	448,606	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	2,009,336	USD
At 2015-12-31	1,239,794	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	-1,643,509	USD
At 2015-12-31	-791,188	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	2,020	USD
At 2015-12-31	24,133	USD
At 2015-09-30	41,354	USD
At 2014-12-31	99,462	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-288,776	USD	92
2016-01-01 to 2016-09-30	-963,005	USD	274
2015-07-01 to 2015-09-30	-366,922	USD	92
2015-01-01 to 2015-09-30	-1,956,766	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-275,142	USD	274
2015-01-01 to 2015-09-30	-477,132	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	8,051	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	41,855	USD	92
2016-01-01 to 2016-09-30	219,480	USD	274
2015-07-01 to 2015-09-30	68,048	USD	92
2015-01-01 to 2015-09-30	278,513	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	260,146	USD	274
2015-01-01 to 2015-09-30	439,795	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-7,117	USD	274
2015-01-01 to 2015-09-30	-20,771	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-14,039,997	USD
At 2015-12-31	-13,076,992	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	21,779	USD
At 2015-12-31	32,686	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	85,707	USD	274
2015-01-01 to 2015-09-30	762,681	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-271,373	USD	92
2016-01-01 to 2016-09-30	-924,713	USD	274
2015-07-01 to 2015-09-30	-333,791	USD	92
2015-01-01 to 2015-09-30	-1,744,974	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	72,644	USD
At 2015-12-31	128,336	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	14,634	USD	92
2016-01-01 to 2016-09-30	39,916	USD	274
2015-07-01 to 2015-09-30	8,362	USD	92
2015-01-01 to 2015-09-30	142,550	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	1,710,689	USD
At 2015-12-31	1,239,794	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2016-09-30	236,404	USD
At 2015-12-31	232,584	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-09-30	5,730	USD
At 2015-12-31	7,098	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	299,799	USD	92
2016-01-01 to 2016-09-30	1,062,814	USD	274
2015-07-01 to 2015-09-30	380,247	USD	92
2015-01-01 to 2015-09-30	1,923,547	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-09-30	28,669	USD
At 2015-12-31	40,323	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	28,426	USD	92
2016-01-01 to 2016-09-30	138,101	USD	274
2015-07-01 to 2015-09-30	46,456	USD	92
2015-01-01 to 2015-09-30	178,573	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	28,146,027	shares
At 2015-12-31	28,107,337	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	12,386,996	USD
At 2015-12-31	12,309,450	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	138,885	USD
At 2015-12-31	138,885	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	117,106	USD
At 2015-12-31	106,199	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	758,923	USD
At 2015-12-31	365,307	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-288,776	USD	92
2016-01-01 to 2016-09-30	-963,005	USD	274
2015-07-01 to 2015-09-30	-366,922	USD	92
2015-01-01 to 2015-09-30	-1,956,766	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	230,357	USD	92
2016-01-01 to 2016-09-30	726,844	USD	274
2015-07-01 to 2015-09-30	215,864	USD	92
2015-01-01 to 2015-09-30	1,217,445	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	14,204	USD	274
2015-01-01 to 2015-09-30	24,989	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,099	USD	92
2016-01-01 to 2016-09-30	3,297	USD	274
2015-07-01 to 2015-09-30	3,372	USD	92
2015-01-01 to 2015-09-30	10,112	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-2,769	USD	92
2016-01-01 to 2016-09-30	-3,084	USD	274
2015-07-01 to 2015-09-30	-31,675	USD	92
2015-01-01 to 2015-09-30	-20,327	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	560,173	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-1,368	USD	274
2015-01-01 to 2015-09-30	-190,654	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-31,654	USD	274
2015-01-01 to 2015-09-30	22,408	USD	273

Inspect the source

Entity: Entia Biosciences, Inc. / CIK 0001408299
Captured: 2026-09-22 19:46 UTC
SEC response SHA-256: 87eeafe4cf9625d2111221a4c2dc5d771c0e1669a38f86f588b6abe3fa046262

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001408299.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))